The ®nding of a very low haemoglobin A 1c (HbA 1c ) (1´4%) in a diabetic patient with fairly high plasma glucose levels prompted haematological investigations, which revealed auto-immune haemolysis and a Hb concentration of 7´7 g/L. Following treatment, both Hb and HbA 1c concentrations increased roughly in parallel until, 4 months later, Hb was 13´8 g/L, HbA 1c 5´2% and plasma glucose was 6´8 mmol/L. This case illustrates that a falling HbA 1c cannot always be attributed to improving glucose control in diabetic patients.
When dif®culty was experienced in obtaining a valid haemoglobin A 1c (HbA 1c ) reading on a Menarini HA-8121 high-performance liquid chromatography (HPLC) system (Menarini Diagnostics, Berkshire, UK) for a blood specimen from a diabetic patient referred by a general practitioner, a repeat sample was requested. However, this also proved dif®cult to assay, the HbA 1c appearing to be very low at about 1´4%. The patient was a 57-year-old woman taking metformin for type 2 diabetes, thyroxine for hypothyroidism and who had been treated with dothiepin, thioridazine and depot injections of Depixol (¯upentixol decanoate) for panic attacks associated with a psychiatric condition. She was receiving lisinopril for hypertension and salbutamol and beclomethasone via an inhaler for asthma.
The patient also attended the hospital diabetes clinic and her record showed that, prior to 16 months ago, her HbA 1c had been around 6´6% (reference range 3´8 to 5´5%) with a random plasma glucose concentration of about 12´0 mmol/L, but 7 months ago it had fallen to 3´5%, at which time her random plasma glucose was 16´9 mmol/L, and only a month ago it had reached 2´1%. Her haematological parameters had been unremarkable, with a haemoglobin concentration of 13´7 g/L when her HbA 1c measurement was 6´6%, but more recent ®gures were not available.
Although the only anomalous feature detectable on the HPLC trace was the unusually low HbA 1c peak, electrospray mass spectrometry was arranged to check for the presence of a haemoglobin variant (which seemed unlikely in view of the change that had occurred over time) and no abnormality was found.
The possibility of a reduced red cell life, e.g. due to haemolysis, was suggested to the patient's general practitioner, who undertook to repeat the assay and to do some haematological testing at her (imminent) next visit. Before that happened, however, the patient was admitted to hospital with a swollen left arm and was diagnosed as suffering a deep vein thrombosis in the axillary subclavian vein; treatment for this was commenced. Routine laboratory testing then revealed that the patient had a haemoglobin concentration of only 7´7 g/L, a blood ®lm typical of auto-immune haemolysis and a strongly positive Coombs' test. Treatment with high doses of prednisolone was commenced and the patient's diabetes controlled using a sliding scale of insulin therapy. She made an uneventful recovery and when discharged approximately two weeks later her haemoglobin was 10´8 g/L. Four months later, it had risen to 13´8 g/L. Her HbA 1c was then 5´2% and plasma glucose 6´8 mmol/L. Figure 1 shows the roughly parallel changes in Hb and HbA 1c .
DISCUSSION
It is well known that alterations to average red cell life can have an effect on HbA 1c measurements, especially in conditions such as haemolytic anaemia, in which destruction of erythrocytes can signi®cantly reduce the time
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Ann Clin Biochem 2001; 38: 406±407 available for glycated Hb to build up. 1,2 Indeed, HbA 1c has even been suggested as a possible screening test for haemolytic anaemia in nondiabetic subjects. 3 It is, however, seldom demonstrated as graphically as in this patient, in whom the clinical picture was complicated by multiple pathology. Judging by the chronology of the changes in HbA 1c , the development of her haemolytic anaemia had started more than 8 months before her admission to hospital with the deep vein thrombosis. It should be borne in mind that, although some parallelism between Hb and HbA 1c was observed, it is not the Hb concentration per se that affects the HbA 1c , but the reduced red cell life. An anaemia not involving a shortened red cell life would not normally be expected to be associated with a low HbA 1c because HbA 1c is expressed as a percentage of the total Hb and the proportion of Hb glycated should be unaffected.
In conclusion, this case illustrates two points: ®rst, that one cannot invariably assume a falling HbA 1c indicates improving diabetic control; and second, that a diagnosis can sometimes be made via a very roundabout route. Since this case, two others have come to light, both diabetics with low HbA 1c levels (2´3% and 3´0%) and haematological evidence of haemolysis. The latter patient was being treated by a haematologist, but those responsible for his diabetic care had not thought to mention it when requesting HbA 1c . It is therefore worth following up unexplained low HbA 1c results by ®rst checking the patient's haematological history. It may even be possible to make a haematological diagnosis from the biochemistry department!
